Trial Search Results

Lymphedema Study for Arm or Leg Lymphedema

This study compares the effectiveness of a study drug versus placebo in the treatment of lymphedema.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):

Intervention(s):

  • Drug: Ketoprofen
  • Drug: Placebo

Phase:

Phase 4

Eligibility


Inclusion Criteria:

   - a history of lymphedema of one or more limbs (unilateral or bilateral), with a
   duration of > 6 months.

Exclusion Criteria:

   - Patients with active cancer, infection or bleeding tendency will be excluded.

   - We will also exclude patients with medical contraindications to NSAIDs, including
   history of allergies, know gastrointestinal intolerance, or other serious systemic
   illness (e.g., renal failure, hepatic dysfunction, congestive heart failure,
   neurological or psychological impairment) that would impair the patients' ability to
   participate.

   - Minors (<18 years of age) *>90 years of age

Ages Eligible for Study

18 Years - 90 Years

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Leslie Roche, RN
650-723-1396
Recruiting